This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Delivered as a Hybrid Event
September 18-21, 2023Boston Convention and Exhibition Center

Christie Marchesseault
Director of Manufacturing at Lyell Immunopharma


Christie has her Bachelor's degree in Biology and Music from Westfield University and her MBA from Boston University. She started her career in autologous cell therapies at Genzyme Biosurgery in Cambridge, Massachusetts, working on both clinical and commercial products.  She continued her cell therapy career working on MACI, a next-generation product for Carticel. Christie ventured into large-scale protein biologics to gain experience in standard biopharma manufacturing and working through consent decree. In 2015, she relocated to Washington state to help bring up a manufacturing facility for Juno Therapeutics. Christie joined Lyell Immunopharma as the head of manufacturing for a new facility being built in Bothell, WA, which will manufacture CAR-T and TIL products to support clinical trials for solid tumors. 

Agenda Sessions

  • Panel Discussion: Building a Culture of Continuous Improvement in Cell Therapy Manufacturing